For instance, FOXC2 is an EMT regulator (Thiery et al., 2009) and promotes cell migration and invasion through EMT in breast cancer, ovarian cancer, prostate cancer, and lung cancer (Hollier et al., 2013). This evidence concerns the gene FOXC2 and breast carcinoma.